
Early MASH risk stratification, drug choice, and aligned coverage could improve outcomes, explained Zobair Younossi, MD.
Supplements and Featured Publications
over 27 years ago
Participating Facultyover 27 years ago
Selected Abstractsover 27 years ago
Bibliography





